Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity
Abstract
OBJECTIVE: Adrenomedullin (AM) is a potent hypotensive peptide which may be implicated in the insulin regulatory system. Acute hyperinsulinemia exerts no influence on plasma AM in normal subjects while no data on obese subjects has been reported. PURPOSE: The aim of the study was to investigate the effect of acute hyperinsulinemia on the plasma AM concentration in patients with uncomplicated obesity. RESEARCH METHODS: We measured the plasma AM levels in 23 obese subjects (BMI 41.9 +/- 9.8 kg/m2), 21 females and 2 males (mean age 31 +/- 7.2 years), before and during a euglycemic hyperinsulinemic clamp. The control group consisted of 43 healthy subjects (HS) (22 males and 21 females; mean age 38 +/- 12 years; BMI 23.3 +/- 3.2 kg/m2). RESULTS: Baseline plasma AM was found to be higher in obese subjects (20.4 +/- 8.4 pg/ml) than in normal subjects (11.3 +/- 0.8 pg/ml) (p < 0.001). A significant increase in the plasma AM levels was observed in obese subjects during acute hyperinsulinemia (from 20.4 +/- 8.4 pg/ml at 0 min to 26 +/- 8.9 pg/ml at 120 min, p < 0.02). Plasma AM concentrations were significantly correlated with insulin levels at 30 min (r = 0.44; p = 0.04) and 120 min (r = 0.40, p = 0.05) during the clamp. DISCUSSION: In conclusion, acute hyperinsulinemia induced a significant increase in the plasma levels of AM in uncomplicated obese subjects. Hyperinsulinemia may, at least in part, regulate levels of AM in obesity, explaining the high levels of the peptide in these subjects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Still being checked.
Cited by
Sorted by citations
Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues
Li, Y., Jiang, C., Wang, X., Zhang, Y., Shibahara, S., & Takahashi, K. (2007) · Peptides · doi:10.1016/j.peptides.2007.03.005 · Cited by 71 · see citing works
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
Frøssing, S., Nylander, M., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Endocrine Connections · doi:10.1530/ec-17-0327 · Cited by 38 · see citing works
Expression of adrenomedullin in adipose tissue of lean and obese women
Paulmyer‐Lacroix, O., Desbrière, R., Poggi, M., Achard, V., Alessi, M., Boudouresque, F., Ouafik, L., Vuaroqueaux, V., Labuhn, M., Dutourand, A., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02170 · Cited by 34 · see citing works
Plasma adrenomedullin level and development of hypertension
Kato, J., Kitamura, K., & Eto, T. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002033 · Cited by 31 · see citing works
Bell, D., Gordon, B. J., Lavery, A., Megaw, K., Kinney, M. O., & Harbinson, M. (2016) · Peptides · doi:10.1016/j.peptides.2015.12.003 · Cited by 15 · see citing works
Adrenomedullin Improves Cardiac Remodeling and Function in Obese Rats with Hypertension
Qian, P., Wang, Q., Wang, F., Dai, H., Wang, H., Gao, Q., Zhou, Y., & Zhou, Y. (2022) · Pharmaceuticals · doi:10.3390/ph15060719 · Cited by 10 · see citing works
Plasma adrenomedullin levels in patients with polycystic ovary syndrome
Ucar, B., Noyan, V., Caglayan, O., Yucel, A., & Sagsoz, N. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.119 · Cited by 5 · see citing works
Sujana, C., Salomaa, V. V., Kee, F., Seißler, J., Jousilahti, P., Neville, C. E., Then, C., Köenig, W., Kuulasmaa, K., Reinikainen, J., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01513-9 · Cited by 3 · see citing works
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000235329.84906.3b
Sujana, C., Salomaa, V. V., Kee, F., Seissler, J., Jousilahti, P., Neville, C., Then, C., Koenig, W., Kuulasmaa, K., Reinikainen, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20046011
- Authors
- Letizia, C., Iacobellis, G., Caliumi, C., Leonetti, F., Cotesta, D., Ribaudo, M., Petramala, L., Cianci, R., Celi, M., D'Erasmo, E., & Di Mario, U.
- Affiliations
- Sapienza University of Rome (IT)
- Venue
- Experimental and Clinical Endocrinology & Diabetes
- Publisher
- Georg Thieme Verlag KG
- Published
- 2005-03-23
- Volume
- 113
- Issue
- 03
- Pages
- 171-175
- ISSN
- 0947-7349 (ISSN-L)
- 1439-3646
- OpenAlex
- W2001676064
- Cited by
- 11
- References
- 0
- Citations by year
- 2022: 3 · 2018: 1 · 2016: 1
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- adrenomedullin, hyperinsulinemia, obesity, hyperinsulinemic-euglycemic clamp, insulin, plasma peptide levels, insulin regulation, adipokines
- MeSH terms
- Acute Disease, Adult, Female, Humans, Hyperinsulinism, Male, Obesity, Osmolar Concentration, Peptides, Case-Control Studies, Adrenomedullin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
